MI
GSK icon

Markowski Investments’s GSK GSK Stock Holding History

Markowski Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.1K Buy
+650
New +$34.4K 0.01% 251

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Markowski Investments's GSK Position: Q2 2026 in Review

Markowski Investments opened a new position in GSK (GSK) in Q2 2026: 650 shares worth $34.1K. The stake represents 0.01% of the portfolio and ranks #251 among its holdings.

878 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Markowski Investments held 650 shares of GSK worth $34.1K as of Q2 2026.
  • GSK was a new Markowski Investments position in Q2 2026.
  • GSK made up 0.01% of Markowski Investments's portfolio in Q2 2026, its #251 holding.
  • 878 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.